We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Spectra Systems Corporation | LSE:SPSY | London | Ordinary Share | COM SHS USD0.01 (UNRES) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 250.00 | 240.00 | 260.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Computer Programming Service | 19.63M | 6.15M | 0.1364 | 19.06 | 117.15M |
Date | Subject | Author | Discuss |
---|---|---|---|
17/10/2014 15:37 | Ozone chambers achieve a 99.99% kill of airbourne bacteria, moulds and viruses, and are easily set up for production lines etc at little cost. Strangely they are currently being looked at for being installed into aircraft ventilation, pre-ebola scare. I am not aware it can be used for body fluids though. | pj 1 | |
17/10/2014 15:35 | Just that it's a bit like asking a crash helmet manufacturer if it will protect from falling aircraft. Ie it's incredibly unlikely but if it does happen you're f@#$%d anyway. | stegrego | |
17/10/2014 15:18 | I don't see anyone getting excited about it, seemed a reasonable question to me. | fugwit | |
17/10/2014 15:15 | I think you may be getting a bit too excited about Ebola. And I don't think viruses could live that long out of a host anyway. | stegrego | |
17/10/2014 15:10 | I tend to agree that there is a misread here. It was already known that the Mexican testing note has a polymer constituent that makes it a less promising prospect, SPSY have made those comments previously so this shouldn't come as too much of a surprise. I dare say there are many that have just jumped to a conclusion or who are only looking at SPSY from the point of view of the aeris project and ignoring the rest of the business. Either way I like cheap stock so today is a happy day. Shanklin; I can't comment on ebola but it is certainly the case that the US FED receive a great deal of returned notes from African & Central American central banks wanting them swapped for new notes. The FED will not handle these notes which are destroyed as previous tests have shown up all sorts of nasties such as ADT & DDT. The UK has the same problem and I presume so does the ECB. Aeris will likely prove to solve this problem which should lead to early sales. | fugwit | |
17/10/2014 13:11 | RmI just added | patviera | |
17/10/2014 13:03 | Interesting thoughts shanklin. Id be fairly certain they haven't done any tests with ebola so presume that's an unknown. What is strange is that the mexico bank only had one test done, why would you do that, it just doesn't make sense to me. Easy to supply enough notes to find optimum test conditions. Unless spectra did do more tests but only provided the results from the best test to Mexico.Strange. | allstar_07 | |
17/10/2014 12:09 | I guess the question one might ask on the cash cleaning front is what happens if a note covered in the ebola (or similar virus) is subjected to the cleaning process. Up until it is subject to the cleaning process, if such a note causes the spread of infection this is not IMHO the responsibility of the central bank. However if a note which is subjected to the cleaning process does subsequently infect somebody, presumably the CB would find itself in the line of fire. Is this a risk it would want to take or are they prepared to pay out vast sums for replacement notes so as to avoid this issue? I have no idea, but I presume this has come up as an issue during testing? | shanklin | |
17/10/2014 09:50 | Not great news. I think we will have a better understanding of the credibility of the cleansing process after the other pilots. Too early to sell for me. Want to see the results of the other pilots. | stewy_18 | |
17/10/2014 09:13 | 18p cash and 19p to buy. Happy days :) | stegrego | |
17/10/2014 08:43 | Well at least i now know where my MAE money is going! | fozzie | |
17/10/2014 08:39 | Well good luck with that Im out One reason is because of the Markets and not even good news is being bought, so Im selling any disappointing news. Surely they run their own tests before involving the Banks. If they do then something is wrong. If they do not then............. Another disappointment and a count to 3 and their knocked out surely? On the watch list still Good luck ! PJ | pj 1 | |
17/10/2014 08:13 | Well at the end of another horrendous week this was definetly not the news i was hoping for. Anyway they want to dress it up this is a failure of the product to do what it says on the tin. The customer was not impressed enough to place an order. Lets not forget how thrilled the company was to secure the tests with BdM. ''We are very pleased that the Banco de Mexico has provided us with the opportunity to collaboratively assess the efficacy and economic impact of our banknote cleaning technology for Mexico's banknotes. Mexico is one of the countries which has adopted polymer notes for its lower denominations and has had extensive experience with the issues of soiling and reducing banknote replacement costs. In addition, the Banco de Mexico has one of the most highly respected central bank research and development teams in the world and has developed important data on banknote life cycles. We are extremely excited about the opportunity to gain their insight on the value of our breakthrough technology'' If memory serves we also lost a G8 bank last year who didnt progress trials beyond a certain stage. Is there a problem with the technology? Why does it take 4 months to test banknotes and reach a conclusion? Where are the test results from the two G8 banks that have been testing? | fozzie | |
17/10/2014 07:48 | Not sure why they are pleased to give this updateBut alls not lost as I think they will get contracts | patviera | |
17/10/2014 07:47 | Failure. "Based on this test, the Banco de Mexico stated that: "specifically for the Mexican banknote mix and design, the cleaning process does not meet the central bank's needs at this time and we will consider a second trial of the cleansing technology for the new series of Mexican banknotes, to be issued in 2019". | someuwin | |
17/10/2014 07:41 | Now we know why! :-( | pj 1 | |
06/10/2014 15:45 | Very good write up. Not sure if stevemp posts here or not. thanks Stewy. I have a small holding here. Like the look of the Co but cannot understand why the Banks would not chase the Bank Note restoration process savings more if they were realistic, especially with the Green side to this. You get the impression that the Banks are just waiting for something to happen via SPSY (edit), but from experience I do not think that is how it works! Just IMO | pj 1 | |
06/10/2014 14:04 | Nice post by stevemp on other place:- | stewy_18 | |
01/10/2014 07:00 | IMHO good set of results & v pleased with the progress SPSY's making. The statement is littered with positives; new manufacturing facility completed leading to margin improvement; Aeris developments continuing to progress; launch of Trubrand smartphone authentication; phosphor sales strong; net cash worth 18p per share underpinning shareprice and cost base reductions on the menu. WHI agree & note Spectra’s interim results demonstrate substantial progress at both the financial and operating levels. First half numbers have benefited from strong sales of higher margin consumable materials, offsetting the slower than expected delivery of sensor hardware (the balance of the sensor contract flowing into FY 2015). Revenues to June 2014 increased 355% to $9.8m. As a consequence, the adjusted EBIT of $0.73m is a substantial improvement on the $1.4m loss reported in H1-13. Spectra exited the period with unrestricted cash of $9.6m, after acquisitions costing $1.0m and the payment of the contingent liability. While the banknote authentication business is performing well again, Spectra’s new technologies in bank note cleaning (Aeris) and mobile brand protection (TruBrand) have made demonstrable progress and could deliver a meaningful contribution in the next few years. Each of these prospects has the potential to realise significant returns for shareholders. Determining the timing remains the biggest risk, although the balance sheet remains in a robust state with $9.6m of unrestricted cash available. With our FY 2014 estimates looking substantially underpinned (revenue $16.3m, profit $1.3m, EPS 1.8p), prospects beyond FY 2014 looking increasingly healthy and with the shares well backed by a cash-strong balance sheet, we retain our Buy recommendation and 40p price target. Regards, GHF | glasshalfull | |
30/9/2014 10:17 | Ah yes just seen those trades come through. Lets hope so ;o) | fozzie | |
30/9/2014 10:15 | WHIreland Reiterates Buy and 40p target lol Big volume? | fozzie | |
30/9/2014 10:10 | big volume director buying? | patviera | |
30/9/2014 09:38 | All good stuff imo. Just one to tuck away and forget. They seem to have everything well in hand and as you say Stewy we are profitable while we await the bigger news. | fozzie |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions